Loading…
Laborie Medical Technologies completed its tender offer for Cogentix Medical at $3.85 per share, acquiring approximately 84.5% of outstanding shares. The merger is expected to close on April 23, 2018, making Cogentix a wholly owned subsidiary.
Laborie Medical Technologies will acquire Cogentix Medical for $3.85 per share in cash, totaling approximately $239 million. The transaction is expected to close in the second quarter of 2018.